Original Communications
Peripheral Arterial Disease: Considerations in Risks, Diagnosis, and Treatment

https://doi.org/10.1016/S0027-9684(15)31066-XGet rights and content

Peripheral arterial disease (PAD), a manifestation of systemic atherosclerosis, is a marker for coronary artery, cerebrovascular, and renal artery atherosclerotic vascular disease. Patients with PAD have an increased risk of cardiovascular events such as myocardial infarction and stroke in addition to significant impairment in their quality of life and physical function. Early detection and implementation of guideline-recommended therapies are paramount to effective treatment of PAD. Measurement of the ankle-brachial index is a simple, reliable, and noninvasive test to diagnose PAD that can be used in a primary care setting. Lifestyle modification, including exercise and smoking cessation, combined with pharmacologic therapy to manage risk factors have been shown effective in reducing cardiovascular risks in patients with PAD.

Evidence suggests, however, that there is currently a lack of awareness regarding PAD among physicians and patients, leading to underdiagnosis and undertreatment. This paper reviews the epidemiology, pathology, and clinical implications of PAD, and offers current evidence for disease management quality improvement initiatives to enhance patient care.

REFERENCES (57)

  • J.A. Dormandy et al.

    Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)

    J Vasc Surg

    (2000)
  • R.S. Dieter et al.

    Classic intermittent claudication is an uncommon manifestation of lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease

    Angiology.

    (2004)
  • E. Selvin et al.

    Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000

    Circulation.

    (2004)
  • W.T. Meijer et al.

    Determinants of peripheral arterial disease in the elderly: The Rotterdam study

    Arch Intern Med.

    (2000)
  • M.H. Criqui et al.

    The prevalence of peripheral arterial disease in a defined population

    Circulation.

    (1985)
  • A.T. Hirsch et al.

    Peripheral arterial disease detection, awareness, and treatment in primary care

    JAMA.

    (2001)
  • Y. Ostchega et al.

    Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004

    J Am Geriatr Soc.

    (2007)
  • W.S. Aronow et al.

    Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility

    J Gerontol A Biol Sci Med Sci.

    (2002)
  • P.J. Levy

    Epidemiology and pathophysiology of peripheral arterial disease

    Clin Cornerstone.

    (2002)
  • D. Hayoz et al.

    Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease

    J Intern Med.

    (2005)
  • H.H. Feringa et al.

    The long-term prognostic value of the resting and postexercise ankle-brachial index

    Arch Intern Med.

    (2006)
  • Scottish Intercollegiate Guidelines Network. Diagnosis and management of peripheral arterial disease: a national...
  • M.H. Criqui et al.

    The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease

    Vasc Med.

    (1998)
  • M.H. Criqui et al.

    Mortality over a period of 10 years in patients with peripheral arterial disease

    N Engl J Med.

    (1992)
  • J.I. Weitz et al.

    Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

    Circulation.

    (1996)
  • R.S. Dieter et al.

    The significance of lower extremity peripheral arterial disease

    Clin Cardiol.

    (2002)
  • S. Tierney et al.

    ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease

    BMJ

    (2000)
  • D.E. Jorenby et al.

    A controlled trial of sustainedrelease bupropion, a nicotine patch, or both for smoking cessation

    N Engl J Med.

    (1999)
  • Cited by (0)

    Financial Disclosure: Dr Cho has received research grants from Bristol-Myers Squibb/Sanofi-Pharmaceuticals Partnership and has spoken for Medtronic.

    Funding/Support: Editorial assistance was funded by Bristol-Myers Squibb/Sanofi-Pharmaceuticals Partnership. The authors did not receive any compensation for this work.

    View full text